# Women seek testosterone for low sex drive as doctors face treatment gaps > Women increasingly use testosterone for menopause symptoms but face insurance barriers and dosing challenges. - Title: Women seek testosterone for low sex drive as doctors face… - Summary: Women increasingly use testosterone for menopause symptoms but face insurance barriers and dosing challenges. Women seeking testosterone for low sexual… - Keywords: testosterone therapy, menopause symptoms, fda approval, insurance denial, off-label prescribing, hypoactive sexual desire disorder, compounded cream, male gel packets, news, politics, Women, seek - Source: Fox News — https://foxnews.com/health/women-turn-testosterone-low-sex-drive-doctors-confront-treatment-experimentation - Author: Khloe Quill - Published: 2026-09-18T00:00:00+00:00 - Read time: 1 min - Topics: testosterone therapy, menopause symptoms, fda approval, insurance denial, off-label prescribing, hypoactive sexual desire disorder, compounded cream, male gel packets, news, politics ## Women seek testosterone for menopause symptoms Women increasingly ask doctors about testosterone to address low sexual desire, fatigue and reduced quality of life during menopause. > Interest in testosterone therapy has grown as more women seek treatment for symptoms such as low sexual desire, fatigue and reduced quality of life during menopause ## No FDA-approved testosterone for women The U.S. Food and Drug Administration has not approved any testosterone product specifically for women despite growing interest in the therapy. > When women ask their doctors about taking testosterone to help with menopause symptoms, they can run into insurance rejections, confusing workarounds and dosing guesswork since no testosterone product is FDA-approved for women in the U.S ## Doctors rely on off-label solutions Physicians use compounded creams or micro-dosed male gels to treat women without FDA-approved testosterone products. > The absence of FDA-approved female testosterone products forces patients to rely on compounded creams, over-the-counter purchases abroad or micro-dosed male gels ## Insurance denies coverage for testosterone Insurance companies routinely deny coverage for testosterone therapy, forcing patients to pay out of pocket for compounded creams or male gels. > When I was prescribed testosterone, my insurance denied coverage, and my physician recommended a compounded cream to avoid the administrative burden ## Dosing challenges with male gels Patients using male gel packets must precisely measure tiny doses, but clinical evidence shows limited hormone level changes and symptom relief. > Despite three months of consistency, follow-up bloodwork showed no change in hormone levels, and the patient experienced no symptom relief ## FDA workshop examines testosterone therapy The FDA convened a public workshop to review evidence, safety and research gaps for testosterone therapy in menopausal women. > On Thursday, the Food and Drug Administration (FDA) convened a public workshop to examine the evidence, safety and research gaps with testosterone therapy for menopausal women ## Doctors advocate for standardized access Doctors emphasize that sexual health is part of overall health and urge regulatory agencies to develop safer, standardized testosterone treatments. > Sexual health is part of your entire health ## Key takeaway Women seeking testosterone for low sexual desire encounter insurance denials and off-label dosing solutions due to lack of FDA-approved products.